ReviewHealthcare (Basel, Switzerland)2025

Filgotinib in Moderate-to-Severe Crohn's Disease: A Network Meta-Analysis of Efficacy and Adverse Events.

Yasser Ali Khoshaim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.